Registry for tracking leptospirosis cases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Leptospirosis Registry - LeptoScope aims to gather comprehensive data on the epidemiology, clinical course, and prognostic factors of invasive leptospirosis disease. This observational study will collect retrospective data on demographics, underlying diseases, and duration of hospitalization from patients diagnosed with invasive leptospirosis. By analyzing this data, the study seeks to enhance understanding of the disease's impact and inform future treatment strategies. The registry will also include matched case controls to provide comparative insights.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cultural, serological, molecular or histological evidence of invasive leptospirosis diseases
* Clinical signs of disseminated leptospirosis disease without cultural, serological, molecular or histological evidence
* Case controls: Matching procedures for controls: Particularly, case controls will be included at the same hospitals that conduced cases based on matching of demographics, underlying diseases and duration of hospitalization (i.e. one control per case, both in the same hospital).

Exclusion Criteria:

* Colonization or other non-invasive infection
* Cultural, serological, molecular or histological evidence without dissemination

Where it's running

• University Hospital of Cologne
  Cologne, North Rhine-Westphalia, Germany Recruiting

Study contacts

• Principal investigator: Felix Köhler, MD — University Hospital of Cologne
• Study coordinator: Felix Köhler, MD
• Email: felix.koehler@uk-koeln.de
• Phone: +4922147897222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Community spread of multiple infectious diseases in Cambodia from a One Health perspective

  This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.

  Recruiting Institut Pasteur du Cambodge · Phnom Penh, Phnom Penh · NCT07358910

• Preventing early and late complications of leptospirosis

  We will test whether measuring complement factor I (CFI) can predict who will develop lung damage from leptospirosis and whether treatments—plasma transfusion, hemoperfusion, or ECMO—help people with complicated leptospirosis.

  Recruiting at 2 sites Phase 2 National Kidney and Transplant Institute, Philippines · Manila, National Capital Region and 2 other locations · NCT07127718

• Leptospirosis care bundle to reduce acute kidney failure

  This will try a care bundle to see if it reduces the chance of acute kidney failure in adults admitted to hospital with suspected leptospirosis.

  Recruiting Chulalongkorn University · Bangkok, Bangkok · NCT05425524

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.